Aerosolized Antibiotics (Part 2) – Mixed News on Two Fronts
![](https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2016/12/Inhalational-Abx-sliderPart2.jpg?resize=640%2C180&ssl=1)
INSMED – NTM The company that is developing Arikayce, a preparation of liposomal amikacin inhalation (LAI), for the treatment of NTM had to withdraw its MAA in Europe earlier this year [1] because data was not convincing enough for regulators to Continue reading Aerosolized Antibiotics (Part 2) – Mixed News on Two Fronts